A Multicenter Phase II Trial of Etoposide, Methylprednisolone, High-Dose Cytarabine, and Oxaliplatin (ESHAOx) for Patients with Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma.
| Autor: | Sym, Sun Jin *, Kang, Hye Jin *, Nam, Seung-Hyun *, Kim, Hoyoung, Kim, Seok Jin *, Eom, Hyeon Seok *, Kim, Won Seog *, Suh, Cheolwon |
|---|---|
| Zdroj: | In Blood 16 November 2007 110(11):3446-3446 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|